A five-day workshop held in Jakarta at the end of October 2015 reviewed and finalized two health technology assessment (HTA) studies in Indonesia. The studies, commissioned by Indonesia’s HTA Committee, were conducted by its Persons in Charge (PICs) in collaboration with Thailand’s Health Inte

The Indonesian HTA Committee (InaHTAC) was formally renewed and continues its work as a facilitator of national HTA studies as of 2016. Under their oversight and technical support provided by iDSI, three HTA economic evaluation studies were completed from 2014-2016: the economic evaluation of

This visit covered the introduction of the Indonesia EQ-5D-5L instrument, the Guide to Health Economic Analysis and Research (GEAR) online resource launch, HTAC’s plans for 2017, and the off-label medicines studies’ stakeholder consultation.

The Indonesian HTA Committee (InaHTAC) was formally renewed and continues its work as a facilitator of national HTA studies as of 2016. Under their oversight, three HTA economic evaluation studies were completed from 2014-2016: the economic evaluation of sildenafil as a first line treatment for pulm

The iDSI Indonesia project aims to institutionalize Health Technology Assessment in the country, to improve health system efficiency, and to prioritize interventions to ensure the longevity of the Universal Health Coverage Scheme or the Jaminan Kesehatan Nasional (JKN). In continuing support toward

The Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Thailand, has been working with the Health Technology Assessment Committee (HTAC), Ministry of Health, Indonesia, since 2014 under the auspices of the International Decision Support Initiative (iDSI). Si